Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2012 Feb 26;5:131–140. doi: 10.1016/S0166-3542(85)80020-6

The interferon system as a basis for antiviral therapy or prophylaxis

A Billiau 1
PMCID: PMC7134133  PMID: 3936410

The content is available as a PDF (905.2 KB).

References

  • 1.Ho M. In: Interferon 1, General and Applied Aspects. Billiau A, Finter NB, editors. Elsevier; Amsterdam: 1984. pp. 79–110. [Google Scholar]
  • 2.Vilcek J. In: Interferon 3, Mechanisms of Production and Action. Friedman RM, Finter NB, editors. Elsevier; Amsterdam: 1984. [Google Scholar]
  • 3.Content J. In: Interferon 1, General and Applied Aspects. Billiau A, Finter NB, editors. Elsevier; Amsterdam: 1984. pp. 125–134. [Google Scholar]
  • 4.Knight E., Jr. In: Interferon 1, General and Applied Aspects. Billiau A, Finter NB, editors. Elsevier; Amsterdam: 1984. pp. 61–75. [Google Scholar]
  • 5.Chany C. In: Interferon 3, Mechanisms of Production and Action. Friedman RM, Finter NB, editors. Elsevier; Amsterdam: 1984. pp. 11–27. [Google Scholar]
  • 6.Edy VG. In: Interferon 1, General and Applied Aspects. Billiau A, Finter NB, editors. Elsevier; Amsterdam: 1984. pp. 117–228. [Google Scholar]
  • 7.Volckaert G. In: Interferon 1, General and Applied Aspects. Billiau A, Finter NB, editors. Elsevier; Amsterdam: 1984. pp. 233–247. [Google Scholar]
  • 8.Gomi K, Morimoto M, Inoue A, Kobayashi H, Deguchi T, Hara T, Nakamizo N. Gann. 1984;75:292–300. [PubMed] [Google Scholar]
  • 9.Billiau A. Arch Virol. 1984;67:121–123. doi: 10.1007/BF01318595. [DOI] [PubMed] [Google Scholar]
  • 10.Lucero MA, Magdelenat H, Fridman WH, Pouillart P, Billardon C, Billiau A, Cantell K, Falcoff E. Eur J Cancer. 1982;18:243–251. doi: 10.1016/0277-5379(82)90043-8. [DOI] [PubMed] [Google Scholar]
  • 11.Billiau A, Heremans H, Ververken H, Van Damme J, Carton H, De Somer P. Arch Virol. 1981;68:19–25. doi: 10.1007/BF01315163. [DOI] [PubMed] [Google Scholar]
  • 12.Heremans H, Billiau A, De Somer P. Infect Immun. 1980;30:513–522. doi: 10.1128/iai.30.2.513-522.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bocci V. Survey Immunol Res. 1982;1:137–143. doi: 10.1007/BF02918338. [DOI] [PubMed] [Google Scholar]
  • 14.Flannery GR, Pelham JM, Gray JD Baldwin RW. Eur J Cancer Clin Oncol. 1984;20:791–798. doi: 10.1016/0277-5379(84)90218-9. [DOI] [PubMed] [Google Scholar]
  • 15.Gurari-Rotman D, Lelkes PI. Biochem Biophys Res Commun. 1982;107:136–143. doi: 10.1016/0006-291x(82)91680-1. [DOI] [PubMed] [Google Scholar]
  • 16.Gresser I, Coppey Y, Falcoff E, Fontaine D. Proc Soc Exp Biol Med. 1967;124:84–91. doi: 10.3181/00379727-124-31672. [DOI] [PubMed] [Google Scholar]
  • 17.Billiau A, Edy VG, Sobis H, De Somer P. Int J Cancer. 1974;14:335–340. doi: 10.1002/ijc.2910140306. [DOI] [PubMed] [Google Scholar]
  • 18.Friedman RM, Chang EH, Ramseur JM, Myers MW. J Virol. 1975;16:569–574. doi: 10.1128/jvi.16.3.569-574.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Billiau A, Heremans H, Allen PT, De Maeyer-Guignard J, De Somer P. Virology. 1976;73:537–542. doi: 10.1016/0042-6822(76)90416-5. [DOI] [PubMed] [Google Scholar]
  • 20.Smedley H, Katzak M, Sikora K, Wheeler T. Lancet. 1983;i:262–264. doi: 10.1136/bmj.286.6361.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Heremans H, Billiau A, Colombatti A, Hilgers J, De Somer P. Infect Immun. 1978;21:925–930. doi: 10.1128/iai.21.3.925-930.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gresser I, Aguet M, Morel-Maroger L, Woodrow D, Purvien-Dutilleul F, Guillon JC, Maury C. Am J Pathol. 1981;102:396–402. [PMC free article] [PubMed] [Google Scholar]
  • 23.Samo TC, Greenberg SB, Couch RB, Quarles J, Johnson PE, Hook S, Harmon MW. J Infect Dis. 1983;148:535–542. doi: 10.1093/infdis/148.3.535. [DOI] [PubMed] [Google Scholar]
  • 24.Negoro Y, Imamishi J, Matsus A, Kishida T. Japan J Ophthalmol. 1980;24:125–127. [Google Scholar]
  • 25.Colin J, Chastel C, Renard G. Am J Ophthalmol. 1983;95:346–348. doi: 10.1016/s0002-9394(14)78303-5. [DOI] [PubMed] [Google Scholar]
  • 26.Ikic D, Bosnic N, Smerdel S, Jusic D, Soos E, Delimar N. Proceedings of Symposium on Clinical Use of Interferon. Yugoslav Academy of Sciences and Arts; Zagreb: 1975. pp. 229–233. [Google Scholar]
  • 27.Billiau A. Med Oncol Tumor Pharmacother. 1984;1:87–96. [PubMed] [Google Scholar]
  • 28.Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP. New Engl J Med. 1978;298:981–987. doi: 10.1056/NEJM197805042981801. [DOI] [PubMed] [Google Scholar]
  • 29.Arvin AM, Feldman S, Merigan TC. Antimicrob Agents Chemother. 1978;13:605–607. doi: 10.1128/aac.13.4.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pazin GJ, Armstrong JA, Lam MT, Tarr GC, Jannetta PJ, Ho M. New Engl J Med. 1979;301:225–230. doi: 10.1056/NEJM197908023010501. [DOI] [PubMed] [Google Scholar]
  • 31.Hirsch M, Schooley RT, Cosimi AB, Russell PS, Delmonico FI, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farrell ML, Rota TR, Rubin RH. New Engl J Med. 1983;308:1489–1493. doi: 10.1056/NEJM198306233082501. [DOI] [PubMed] [Google Scholar]
  • 32.Schalm SW, Heijtink RA. Hepathology. 1982;2:791–794. doi: 10.1002/hep.1840020608. [DOI] [PubMed] [Google Scholar]
  • 33.Goepfert HG, Sessions RB, Gutterman JU, Cangir A, Dichtel WJ, Sulek M. Ann Otol Rhinol Laryngol. 1982;91:431–436. doi: 10.1177/000348948209100422. [DOI] [PubMed] [Google Scholar]
  • 34.Krown SE, Real FX, Cunningham-Rundles S, Myskowski PL, Koziner B, Fein S, Mittelman A, Safai B. New Engl J Med. 1983;308:1071–1076. doi: 10.1056/NEJM198305053081806. [DOI] [PubMed] [Google Scholar]

Articles from Antiviral Research are provided here courtesy of Elsevier

RESOURCES